Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
Learn more about:
Related Clinical Trial
Non-invasive Quantification of Liver Iron With MRI
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
Pharmacogenetic Study in Patients Received Iron Chelating Agent
Efficacy Study in Removing Excess Iron From the Heart
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
Safety, Tolerability, and Efficacy of Deferasirox in MDS
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)